Carregant...
Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly
Stroke is a major cause of both death and disability. However, there are no pharmacological treatments used in most countries other than recombinant tissue plasminogen activator, a thrombolytic, and this is only used in about 4% of patients presenting after an acute ischaemic stroke. One novel throm...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2268079/ https://ncbi.nlm.nih.gov/pubmed/18059324 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0707594 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|